Bert is a former President of Eli Lilly Neuroscience Products and an executive advisor to Revalesio for all therapeutic programs. He has over 40 years of working experience in the global pharmaceutical industry, mainly in general management, product development, and administration. Bert worked for Eli Lilly and Company for nearly three decades in Belgium, The Netherlands, Indonesia, Venezuela, Germany, UK, and USA.

Prior to his career in industry where he was Vice President of Neuroscience at Eli Lilly (1998-2003), Amgen (2003-2007), Biovail (2007-2010), and Chief Scientific Officer at MedGenesis Therapeutix (2011-2017), Chris was Professor of Neurological Sciences at the University of British Columbia.  He presently serves as a consultant or Board member for a number of neuroscience related biotechnology companies. Chris graduated from the University of Victoria in 1966 having earned a B.Sc. in Chemistry and Psychology, and from Princeton University in 1970 with a Ph.D. in Psychopharmacology.

Liam is the President of the Lace'em Up Foundation for Kids and Vice President of Business Development at Cannonball Capital. Previously, Liam was a business analyst at Fraction Energy Services Ltd., an energy services start up that was sold to Canyon Services Group in 2014. Prior to working at Fraction, Liam worked as an investment banking analyst at Morgan Stanley and Raymond James. He graduated from Concordia in 2009, earning a Bachelor of Commerce Degree, majoring in Finance.

Matt Ireland is a Co-CEO and Managing Director for Cumming Capital Management, overseeing the strategic direction of the company with a primary focus on investment strategy. He works closely with investment partners and the executive teams of portfolio companies. Matt serves as an active board member and advisor for multiple companies. He has extensive experience in M&A, strategy, executive management, and tax/estate planning. Prior to working for Cumming Capital, Matt worked for Leucadia National Corporation in M&A, operations, and asset management. Previous to Leucadia, he worked for Deloitte. Matt received his BS and MS in Accountancy with an emphasis in information systems from the Marriott School of Management at Brigham Young University. He also received an MBA from the Kellogg School of Management at Northwestern University.

Jim Nordstrom, a former Co-President of Nordstrom, Inc., is Managing Director of Northern Stream Capital, LLC, a private equity investment firm in Bellevue, Washington. As a member of the fourth generation of the Nordstrom family, Jim grew up in the retail business. After graduating from the University of Southern California in 1985, his career at Nordstrom spanned many areas including sales, buying, merchandising, and management. After retiring from the family business in 2000, Jim founded Northern Stream Capital. The private equity firm makes investments in early-stage companies. While the portfolio is diversified, the firm has a particular focus on companies specializing in water technology and nanotechnology.

Eric Russell is the Founder of Revalesio Corporation. After acquiring the technology in 2004, Eric led the strategic development of Revalesio as the company’s Chairman and CEO over the next decade. Prior to founding Revalesio, Eric served in a variety of roles at the Frank Russell Company, including President of Frank Russell Investment Management Company from 1996-2000, a member of the Executive Committee and Board of Directors. Assets in the investment business more than tripled under his leadership. Eric is a founding board member of The Russell Family Foundation and currently serves as Board President. He also serves on the Board of Tiedemann Advisors after leading the strategic sale of the Russell family’s multifamily wealth management company, Threshold Group, to Tiedemann Advisors in 2017. He earned a B.A. in Economics and Environmental Studies from Williams College in Massachusetts (1984) and an MBA at the UW Foster School of Business (1990).

Jane Taylor received her baccalaureate degree in Nursing from the University of Washington Medical Center in 1979. After working as a Critical Care nurse at Harborview Medical Center, she moved into the field of pharmaceutical research. She founded PC3Inc, a site management organization in 1988 (sold to Americas Doctor in 1996), The Geneva Foundation, a non-profit that supports medical research at over 55 military treatment facilities and federal laboratories worldwide, in 1993, and Northwest Kinetics, Inc, a Phase I pharmacokinetic clinical research unit, in 1995 (sold to Charles River Laboratories in 2006).

Jane has a known track record for successfully leading and growing for-profit and non-profit organizations. She serves on many Boards and is actively involved in her community. Jane has received many accolades for her leadership and her service, including the University of Washington-Tacoma Milgard School of Business 2015 Non-Profit Business Leader of the Year and the Tacoma Business Examiner’s 2015 Woman of Influence award.